Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders - A review

Kenichi Kaida, Toshio Ariga, Robert K Yu

Research output: Contribution to journalReview article

79 Citations (Scopus)

Abstract

Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.

Original languageEnglish (US)
Pages (from-to)676-692
Number of pages17
JournalGlycobiology
Volume19
Issue number7
DOIs
StatePublished - Jun 8 2009

Fingerprint

Gangliosides
Antibodies
Antigens
Campylobacter jejuni
Lymphocytes
Polyradiculoneuropathy
Campylobacter Infections
Molecular Mimicry
Neurology
Human engineering
Inborn Genetic Diseases
Quadriplegia
Autoantibodies
Haemophilus influenzae
Peripheral Nervous System
Epitopes
Humoral Immunity
Cytomegalovirus
Peripheral Nerves
Cellular Immunity

Keywords

  • Bacterial infection
  • Guillain-Barré syndrome
  • Inflammation
  • Llipopolysaccharides
  • Molecular mimicry
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Biochemistry

Cite this

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders - A review. / Kaida, Kenichi; Ariga, Toshio; Yu, Robert K.

In: Glycobiology, Vol. 19, No. 7, 08.06.2009, p. 676-692.

Research output: Contribution to journalReview article

@article{8775f8cde83c4c63be3524de34557d93,
title = "Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr{\'e} syndrome and related disorders - A review",
abstract = "Guillain-Barr{\'e} syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.",
keywords = "Bacterial infection, Guillain-Barr{\'e} syndrome, Inflammation, Llipopolysaccharides, Molecular mimicry, Peripheral neuropathy",
author = "Kenichi Kaida and Toshio Ariga and Yu, {Robert K}",
year = "2009",
month = "6",
day = "8",
doi = "10.1093/glycob/cwp027",
language = "English (US)",
volume = "19",
pages = "676--692",
journal = "Glycobiology",
issn = "0959-6658",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders - A review

AU - Kaida, Kenichi

AU - Ariga, Toshio

AU - Yu, Robert K

PY - 2009/6/8

Y1 - 2009/6/8

N2 - Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.

AB - Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.

KW - Bacterial infection

KW - Guillain-Barré syndrome

KW - Inflammation

KW - Llipopolysaccharides

KW - Molecular mimicry

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=66249125014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66249125014&partnerID=8YFLogxK

U2 - 10.1093/glycob/cwp027

DO - 10.1093/glycob/cwp027

M3 - Review article

VL - 19

SP - 676

EP - 692

JO - Glycobiology

JF - Glycobiology

SN - 0959-6658

IS - 7

ER -